Literature DB >> 7697705

The International Headache Society (IHS) headache classification as applied to a headache clinic population.

L C Sanin1, N T Mathew, L R Bellmeyer, S Ali.   

Abstract

Four hundred patients attending a headache clinic were classified using the IHS criteria. The majority required more than two, often three or four, diagnoses. Even though migraine was the most common diagnosis, only 1/4 of those with a migraine diagnosis had it as the only diagnosis. Seventy-five percent of migraine patients had coexistent chronic tension-type headache (CTTH), drug-induced headache or both. Ninety-six percent of patients diagnosed as having migraine with aura also suffered from migraine without aura. More than 1/3 of patients (37.7%) attending the clinic suffered from chronic daily headache (CDH) (chronic cluster headache excluded), which is not included as a separate entity in the IHS classification. Pure CTTH formed only a small minority of CDH, whereas 86.6% of CDH had migraine as one of the diagnoses. Drug-induced headache was a prominent second or third diagnosis. The advantages and disadvantages of multiple verses single diagnosis in CDH and the need to recognize the natural history of headache disorders in the classification are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7697705     DOI: 10.1046/j.1468-2982.1994.1406443.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

Review 1.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Diagnostic issues in tension-type headache.

Authors:  Sara Sacco
Journal:  Curr Pain Headache Rep       Date:  2008-12

3.  Children and adolescents with chronic daily headache.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2004-02

Review 4.  Tension-type headache.

Authors:  Ninan T Mathew
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

Review 5.  Chronic headache and sleep disturbance.

Authors:  Jeanetta C Rains; Donald B Penzien
Journal:  Curr Pain Headache Rep       Date:  2002-12

Review 6.  Epidemiology of chronic daily headache.

Authors:  J Pascual; R Colás; J Castillo
Journal:  Curr Pain Headache Rep       Date:  2001-12

7.  Refractory migraine in a headache clinic population.

Authors:  Pablo Irimia; Jose-Alberto Palma; Roberto Fernandez-Torron; Eduardo Martinez-Vila
Journal:  BMC Neurol       Date:  2011-08-01       Impact factor: 2.474

8.  A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache.

Authors:  Shengyuan Yu; Yueqing Hu; Qi Wan; Jiying Zhou; Xinfeng Liu; Xiangyang Qiao; Xiaosu Yang; Jiachun Feng; Kangning Chen; Xiaoping Pan; Qingwu Yang; Linsen Dou; Ming Liu; Yangmei Chen; Tingmin Yu; Juming Yu; Zhiwei Li; Xue Bai; Jingfeng Duan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-26       Impact factor: 2.629

9.  The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study.

Authors:  Sun-Young Kim; Sung-Pa Park
Journal:  J Headache Pain       Date:  2014-10-02       Impact factor: 7.277

10.  Field testing of the ICHD-3β and expert opinion criteria for chronic migraine.

Authors:  Huahua Jiang; Yong Deng; Yixin Zhang; Jieli Jin; Xueying Kong; Qiuwen Zhu; Kuiyun Wang; Jiying Zhou
Journal:  J Headache Pain       Date:  2016-09-19       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.